For patients with newly diagnosed multiple myeloma (NDMM) receiving dexamethasone induction, dose reductions do not ...

Dexamethasone reduced mortality among patients hospitalized with COVID-19, especially those who were also receiving respiratory support.

The mean age of patients treated with dexamethasone was 36.27 ± 13.38 and in group treated with intravenous propofol was 35.65 ± 12.55 years. Independent T-test results showed no significant ...

Opens in a new tab or window Modifying the quadruplet regimen of isatuximab, bortezomib, lenalidomide, and dexamethasone could allow older, frail patients with transplant-ineligible multiple ...

Data from the study showed that the new SC formulation of Sarclisa in combination with Bristol Myers’ BMY Pomalyst (pomalidomide) and dexamethasone (Pd) when administered through an on-body ...

Data from the study showed that the new SC formulation of Sarclisa in combination with Bristol Myers’ BMY Pomalyst (pomalidomide) and dexamethasone (Pd) when administered through an on-body ...

Group I received propofol and group II received dexamethasone ... a curtain separating the hands and upper body of the patient from the lower part was utilized to prevent the performer from ...